All companies
UnitedHealth Group Incorporated logo

What smart money is saying about UnitedHealth Group IncorporatedUnited States flag

UNH · Healthcare · Medical - Healthcare Plans · Market cap $264.47B

13 funds in our archive have pitched UnitedHealth Group Incorporated — most recently Baron Health Care Fund in June 2026.

Company profile

UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.

Get an email when a fund writes about it

Summarize with Warren AI
17
Reported positions
4
Bought
5
Sold
29
Letters

Position history

Between Q2 2025 and Q2 2026, 17 fund letters reported a position in UnitedHealth Group Incorporated4 opened or added to the position, 5 trimmed or exited.

Fund letters reporting a position in UnitedHealth Group Incorporated, by quarter
QuarterLettersBoughtSoldTheses
Q2 202613451
Q1 20264001
Q4 20250002
Q3 20250003
Q2 20250006

Fund activity · 17 positions · 9 moves

  • We exited Diageo in consumer staples, DTE Energy in utilities, L3Harris Technologies in industrials, UnitedHealth in health care and Freeport-McMoRan in materials.
    UnitedHealth Group Incorporated
  • We reestablished positions in UnitedHealth and Elevance during the quarter as discussed below in the Recent Activity section.
    UnitedHealth Group Incorporated
  • Health care also contributed, with CVS Health and UnitedHealth Group benefiting from improved sentiment toward managed care. CVS rose as stronger first-quarter earnings, raised full-year guidance and better performance in its health benefits business supported confidence in the company’s turnaround, while reduced policy uncertainty around exchange subsidies also helped. UnitedHealth advanced as better cost trends and a more favorable outlook helped rebuild confidence after prior pressure on margins.
    UnitedHealth Group Incorporated
  • June 2026
    Re-United Healthcare At the beginning of the quarter, we significantly added to UnitedHealth, approximately doubling the size of the position.
    UnitedHealth Group Incorporated
  • UnitedHealth is the largest private health insurer in the country. We purchased UnitedHealth Group a little over a year ago after its stock price had declined from approximately $600 per share to under $300 per share as the company missed earnings and replaced its CEO. As a reminder, UnitedHealth Group has been on the MVP list for a number of years and we have owned it successfully several times over the last decade. After a thorough review of the company’s competitive position and assessment of the new management team, we determined that UnitedHealth Group’s value was stable and that the company should be able to return to steady earnings growth within a year or so. Since that time the company has executed even better than we expected. “Mr. Market” is beginning to recognize what we saw a year ago and UnitedHealth Group’s discounted shares are beginning to recover. In fact, the company’s stock increased by more than 35% through the first half of the quarter prior to our exit while our value remained stable. Following our discipline, we sold UnitedHealth Group in our Focus portfolio to reallocate capital into meaningfully more discounted companies whose values are compounding at attractive double-digit rates.
    UnitedHealth Group Incorporated
  • UnitedHealth Group Inc (UNH) traded higher after reporting results that were better than consensus feared, with signs of greater stability in care utilization trends.
    UnitedHealth Group Incorporated
  • June 2026
    A year ago, we wrote to you about the travails of our UnitedHealth investment. The stock lost over half its value in about a month, an extraordinary change for a steady business that serves as the health insurance provider to one in seven Americans. There were two core problems the company faced: unexpectedly higher healthcare usage and chasing unprofitable business. The company has since executed on its turnaround plan, raising rates to reflect the higher usage and getting out of markets it couldn’t make money in. We bought more after the stock tanked, and it has since rebounded, returning 37% over the past year and 80% off its lows.
    UnitedHealth Group Incorporated
  • We also exited Rio Tinto, Newmont, National Australia Bank, Visa, UnitedHealth and Nike, taking the total to fourteen positions sold and thirteen initiated: unusually high turnover for this Fund, and a deliberate response to the concentration above.
    UnitedHealth Group Incorporated
  • We also exited Rio Tinto, Newmont, National Australia Bank, Visa, UnitedHealth and Nike, taking the total to fourteen positions sold and thirteen initiated: unusually high turnover for this Fund, and a deliberate response to the concentration above.
    UnitedHealth Group Incorporated
  • June 2026
    A year ago, we wrote to you about the travails of our UnitedHealth investment. The stock lost over half its value in about a month, an extraordinary change for a steady business that serves as the health insurance provider to one in seven Americans. There were two core problems the company faced: unexpectedly higher healthcare usage and chasing unprofitable business. The company has since executed on its turnaround plan, raising rates to reflect the higher usage and getting out of markets it couldn’t make money in. We bought more after the stock tanked, and it has since rebounded, returning 37% over the past year and 80% off its lows.
    UnitedHealth Group Incorporated
  • UnitedHealth and CVS both rose on increased market optimism around stabilizing medical cost trends and improved Medicare Advantage margins.
    UnitedHealth Group Incorporated
  • HoldsHomestead Advisers Value Fund
    June 2026
    UnitedHealth Group has seen the higher utilization and cost trends that pressured Medicare Advantage over the past couple of years begin to abate, which should lead to a better operating environment.
    UnitedHealth Group Incorporated
  • We sold UnitedHealth Group in our Focus portfolio to reallocate capital into meaningfully more discounted companies whose values are compounding at attractive double-digit rates.
    UnitedHealth Group Incorporated
  • Listed in HL Global Carbon Transition Equity’s reported holdings.

    UnitedHealth Group Incorporated
  • Portfolio Holdings Data as of March 31, 2026. Source: FactSet, Hardman Johnston Global Advisors LLC®. The data shown is of a representative portfolio for the Hardman Johnston Select Equity strategy and is for informational purposes only and is not indicative of future portfolio characteristics/returns. Actual results may vary for each client due to specific client guidelines and other factors. The representative portfolio was chosen as most representative of the Select Equity strategy. Future investments may or may not be profitable. C ountry We ig ht ( %) Indus try Communicat ion Serv ices 8.1 Alphabet Inc. United States 7.1 Interactive Media & Services Comcast Corp. United States 0.9 Diversified Telecommunication Services Versant Media Group, Inc. United States 0.1 Media Consumer Discret ionary 2.7 SharkNinja, Inc. United States 2.7 Household Durables Consumer St aples 0.8 Estee Lauder Companies Inc. United States 0.8 Personal Care Products Energy 1.9 Cameco Corporation Canada 1.9 Oil, Gas & Consumable Fuels Financials 9.7 Charles Schwab Corp United States 3.0 Capital Markets Marsh & McLennan Cos. Inc. United States 3.0 Insurance Mastercard Inc. United States 3.8 Financial Services H ealt h Care 17.9 AstraZeneca plc United Kingdom 3.5 Pharmaceuticals Becton, Dickinson & Co. United States 1.4 Health Care Equipment & Supplies Edwards Lifesciences Corp. United States 2.8 Health Care Equipment & Supplies Illumina, Inc. United States 2.0 Life Sciences Tools & Services IQVIA Holdings Inc. United States 1.9 Life Sciences Tools & Services Medtronic plc United States 1.7 Health Care Equipment & Supplies UnitedHealth Group Inc. United States 1.0 Health Care Providers & Services
    UnitedHealth Group Incorporated
  • There were seven material detractors to performance: Ares Management Corporation, Ryan Specialty Holdings, Inc., Microsoft Corporation, Salesforce, Inc., UnitedHealth Group Incorporated, Amazon.com, Inc., and SAP SE.
    UnitedHealth Group Incorporated
  • March 2026
    UnitedHealth Group and Humana, two of the leading providers of managed care, have significant scale advantages in a consolidated industry that outgrows the overall economy.
    UnitedHealth Group Incorporated

Fund coverage · 13 theses

  • UnitedHealth provides diversified managed care services, with improving insurance-cycle fundamentals, AI-driven cost savings, and margin recovery potential.

    Read the full thesis
  • UnitedHealth Group is a leading managed care provider with scale advantages and improving margins and earnings growth.

    Read the full thesis
  • Sequoia Fund
    December 2025

    UnitedHealth Group is a core managed care holding bought opportunistically, with cyclical under-earning and policy risks but long-term attractiveness at current levels.

    Read the full thesis
  • UnitedHealth Group is the largest US managed care company, taking margin and portfolio actions that support improved profitability and more consistent earnings growth at a reasonable valuation.

    Read the full thesis
  • UnitedHealth Group Incorporated is a strong managed health care company with new management and reset earnings guidance, facing challenges but possessing competitive advantages and trading at a near 10-year low valuation.

    Read the full thesis
  • The London Company
    September 2025

    UnitedHealth Group is a leading and diversified health insurer in the U.S. with a unique integrated model and strong long-term growth potential, despite temporary challenges from elevated medical costs.

    Read the full thesis
  • UnitedHealth Group is a leading diversified managed care organization positioned for growth and margin recovery following a turnaround under new leadership, with a strong focus on operational discipline and cost reduction initiatives.

    Read the full thesis
  • UnitedHealth is a robust healthcare franchise with a strong integrated model poised for long-term value creation despite short-term volatility.

    Read the full thesis
  • UnitedHealth Group Incorporated is a leading U.S. healthcare enterprise that integrates a dominant health benefits platform with a high-growth health services business, creating a synergistic model that enhances efficiency, lowers costs, and drives sustainable growth.

    Read the full thesis
  • UnitedHealth Group is a defensive investment that was exited due to rising uncertainty from increased medical loss ratios, lowered guidance, and regulatory risks.

    Read the full thesis
  • Bretton Fund
    June 2025

    UnitedHealth Group is a strong investment opportunity with a solid track record and attractive valuation, despite current challenges and risks.

    Read the full thesis
  • Despite recent EPS headwinds from rising utilisation costs, UNH offers an attractive risk-reward profile with resilient earnings growth potential and a compelling valuation floor that supports a $290–$375 price range.

    Read the full thesis
  • UnitedHealth is facing short-term challenges due to internal execution issues and mispricing but remains a strong long-term investment prospect given its discounted valuation and the expected corrections through annual repricing cycles.

    Read the full thesis

Read every full thesis on UnitedHealth Group Incorporated

Unlock all 13 theses — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.

View plans
Share this ledger